What are the common symptoms of withdrawal from Modafinil (Provigil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Modafinil withdrawal symptoms, although not extensively studied, can include fatigue, sleepiness, depression, anxiety, irritability, and difficulty concentrating, with severity correlating to dosage and duration of use 1.

Overview of Modafinil Withdrawal

Studies on modafinil withdrawal are limited, but available data indicate that symptoms can arise from discontinuation, particularly after prolonged use or at higher doses. The mechanism of modafinil, affecting dopamine, norepinephrine, and other neurotransmitters, suggests that withdrawal could lead to temporary imbalances as the brain adjusts.

Symptoms and Management

Common symptoms of modafinil withdrawal include:

  • Fatigue
  • Sleepiness
  • Depression
  • Anxiety
  • Irritability
  • Difficulty concentrating These symptoms typically begin within 24-48 hours after stopping the medication and may last for a few days to weeks.

Recommendations for Withdrawal

To minimize withdrawal effects, tapering the dose gradually rather than stopping abruptly is recommended 1. Additionally, some users find that supplementing with B vitamins, staying hydrated, and maintaining good sleep hygiene can help manage symptoms. If you've been taking modafinil regularly, especially at higher doses or for extended periods, consulting with a healthcare provider before discontinuing to develop an appropriate tapering schedule and management plan for potential withdrawal symptoms is advised 1.

From the FDA Drug Label

Modafinil tablets has been evaluated for safety in over 3,500 patients, of whom more than 2,000 patients with excessive sleepiness associated with OSA, SWD, and narcolepsy The most frequent reasons for discontinuation that occurred at a higher rate for modafinil tablets than placebo patients were headache (2%), nausea, anxiety, dizziness, insomnia, chest pain, and nervousness (each <1%).

There are no studies on modafinil withdrawal mentioned in the provided drug label. Common symptoms of modafinil discontinuation are not explicitly stated as withdrawal symptoms, but the most frequent reasons for discontinuation were:

  • Headache
  • Nausea
  • Anxiety
  • Dizziness
  • Insomnia
  • Chest pain
  • Nervousness 2

From the Research

Modafinil Withdrawal Studies

  • There are limited studies on modafinil withdrawal, but available evidence suggests that modafinil is unlikely to be associated with withdrawal phenomena 3.
  • A study found no evidence of a withdrawal phenomenon, such as fatigue, vivid or unpleasant dreams, insomnia, or hypersomnia, after treatment cessation 3.
  • However, a rare case of modafinil dependence has been reported, suggesting that modafinil may have some abuse/addictive potential 4.

Common Symptoms

  • Common adverse events with modafinil include insomnia, headache, nausea, nervousness, and hypertension 5.
  • Decreased appetite, weight loss, and serious dermatological events have been reported with greater frequency in children and adolescents 5.
  • Fatigue, mood disturbances, and decreased quality of life are common symptoms in patients with narcolepsy, but modafinil treatment has been shown to improve these symptoms 6.

Effects of Modafinil Treatment

  • Modafinil treatment has been shown to improve health-related quality of life, reduce fatigue, and improve mood in patients with narcolepsy 6.
  • Modafinil has also been found to improve cognitive function, particularly in attention and executive function tasks, in patients undergoing withdrawal from methamphetamine dependence 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.